BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1954342)

  • 1. Mutations in diphtheria toxin to improve immunotoxin selectivity and understand toxin entry into cells.
    Youle RJ
    Semin Cell Biol; 1991 Feb; 2(1):39-45. PubMed ID: 1954342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity.
    Greenfield L; Johnson VG; Youle RJ
    Science; 1987 Oct; 238(4826):536-9. PubMed ID: 3498987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A C terminus cysteine of diphtheria toxin B chain involved in immunotoxin cell penetration and cytotoxicity.
    Dell'Arciprete L; Colombatti M; Rappuoli R; Tridente G
    J Immunol; 1988 Apr; 140(7):2466-71. PubMed ID: 2965187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
    Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
    Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line.
    Liu YY; Gordienko I; Mathias A; Ma S; Thompson J; Woo JH; Neville DM
    Protein Expr Purif; 2000 Jul; 19(2):304-11. PubMed ID: 10873546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a diphtheria toxin mutant conjugate directed against antigen-specific B cells expressing high affinity surface Ig.
    Marsh JW; Klinman DM
    J Immunol; 1990 Feb; 144(3):1046-51. PubMed ID: 2295812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
    Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
    Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein engineering of diphtheria toxin. Development of receptor-specific cytotoxic agents for the treatment of human disease.
    Murphy JR; Lakkis FG; vanderSpek JC; Anderson P; Strom TB
    Targeted Diagn Ther; 1992; 7():365-82. PubMed ID: 1633299
    [No Abstract]   [Full Text] [Related]  

  • 9. The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography.
    Sung C; Dedrick RL; Hall WA; Johnson PA; Youle RJ
    Cancer Res; 1993 May; 53(9):2092-9. PubMed ID: 8481911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of immunotoxin efficacy by acid-cleavable cross-linking agents utilizing diphtheria toxin and toxin mutants.
    Neville DM; Srinivasachar K; Stone R; Scharff J
    J Biol Chem; 1989 Sep; 264(25):14653-61. PubMed ID: 2475487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
    Wenning LA; Murphy RM
    Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphtheria toxin-based receptor-specific chimaeric toxins as targeted therapies.
    Sweeney EB; Murphy JR
    Essays Biochem; 1995; 30():119-31. PubMed ID: 8822152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral immunotoxin gene therapy of acute myelogenous leukemia in mice using cytotoxic T cells transduced with an interleukin 4/diphtheria toxin gene.
    Vallera DA; Jin N; Baldrica JM; Panoskaltsis-Mortari A; Chen SY; Blazar BR
    Cancer Res; 2000 Feb; 60(4):976-84. PubMed ID: 10706113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding.
    Sung C; Youle RJ; Dedrick RL
    Cancer Res; 1990 Nov; 50(22):7382-92. PubMed ID: 2224866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic acid 141 of the diphtheria toxin receptor (HB-EGF precursor) is critical for toxin binding and toxin sensitivity.
    Hooper KP; Eidels L
    Biochem Biophys Res Commun; 1996 Mar; 220(3):675-80. PubMed ID: 8607824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of a critical diphtheria toxin-binding domain to the C-terminus of the mature heparin-binding EGF-like growth factor region of the diphtheria toxin receptor.
    Hooper KP; Eidels L
    Biochem Biophys Res Commun; 1995 Jan; 206(2):710-7. PubMed ID: 7826391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Point mutations in tox promoter/operator and diphtheria toxin repressor (DTXR) gene associated with the level of toxin production by Corynebacterium diphtheriae strains isolated in Belarus].
    Kolodkina VL; Titov LP; Sharapa TN; Drozhzhina ON
    Mol Gen Mikrobiol Virusol; 2007; (1):22-9. PubMed ID: 17354605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extension of juxtamembrane domain of diphtheria toxin receptor arrests translocation of diphtheria toxin fragment A into cytosol.
    Takahashi T; Umata T; Mekada E
    Biochem Biophys Res Commun; 2001 Mar; 281(3):690-6. PubMed ID: 11237713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPI-anchored diphtheria toxin receptor allows membrane translocation of the toxin without detectable ion channel activity.
    Lanzrein M; Sand O; Olsnes S
    EMBO J; 1996 Feb; 15(4):725-34. PubMed ID: 8631294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
    Youle RJ; Uckun FM; Vallera DA; Colombatti M
    J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.